Search results

Back
1 - 10 of 393 Search results
 - 2 mins read

 - 2 mins read

Balancing benefit and risk: Nisha Vora on the science of pharmacovigilance

“My job is to be a guardian of patient safety.”As Safety Science Director, she works across both early development and post-marketing, ensuring that risks are anticipated, analyzed, and managed so treatments can reach patients responsibly....


 - 2 mins read

 - 2 mins read

A Life in Science: Shaping early development with patient focus

New in our A Life in Science series, we hear from Mary Jane Hinrichs, Senior Vice President and Head of Early Development, about her path from discovering a passion for pharmacology to leading drug candidates through first-in-human trials. She shares how...


 - 2 mins read

 - 2 mins read

Moving NET Science Forward Together at ENETS 2026

An article by Dr Marius Tham, Director Global Medical Affairs, Ipsen ...


 - 2 mins read

 - 2 mins read

From idea to impact: accelerating the promise of early science

By Christelle Huguet, EVP & Head of R&D, Ipsen...


 - 1 min read

 - 1 min read

Right medicine, right person: Jacintha Sivarajah on science with purpose

“All medicines have side effects, but it's just about trying to minimize the impact through providing the information patients and clinicians need or finding other ways to mitigate that impact.” — Jacintha Sivarajah ...


 - 2 mins read

 - 2 mins read

Bold Science, Bold Ambition: Shaping the Future of Oncology at Ipsen

Ivan Diaz-Padilla, Senior Vice President and Global Head, Oncology Therapeutic Area Unit, R&D at Ipsen, shares his vision for building a balanced and sustainable pipeline powered by bold science....


 - 2 mins read

 - 2 mins read

From culture to clinic: Alison Mason on making science work at scale 

“We’re doing real science. For real people. And we’re doing it together. That’s what matters most to me.” – Alison Mason ...


 - 2 mins read

 - 2 mins read

Faire progresser la science ensemble à l’ENETS 2026

Un article par le Dr Marius Tham, Directeur Affaires Médicales Globales, Ipsen...


 - 2 mins read

 - 2 mins read

Bridging science and leadership: Elisabetta Leo on guiding early development at Ipsen

“I felt, during my career path, that I was more a scientist rather than a leader; in my current role, I’m bridging the two as a research leader.” ...


 - 2 mins read

 - 2 mins read

Why evidence matters: Seema Meloni on making data meaningful  

“In order to help all partners understand the value of a medicine, we provide the wrap-around support of data coming out of clinical trials.” ...


1 2 3 4 40